Secondary Blood Grouping and Sickle Testing

The procurement process, conducted by NHS Blood and Transplant, focused on the provision of secondary blood grouping and sickle cell testing services. The contract, titled "Secondary Blood Grouping and Sickle Testing," falls under the blood analysis services category and was intended to supply automated blood group testing equipment for multiple uses, including antibody screening and sickle cell trait screening. The request for procurement followed a limited method due to the lack of suitable tenders in an open procedure, with an award made to IBG Immucor Ltd on 25th July 2025.

The procurement was classified as a managed service contract, with a total contract value of £6,240,000 for services across the UK. This tender represents a significant business growth opportunity for companies operating within the healthcare technology sector, specifically those specialising in blood analysis and automated testing solutions. Although the contract was awarded without a competitive tender process, it highlights the demand for innovative and efficient diagnostic equipment in the public health sector.

Businesses that can offer advanced technological solutions capable of meeting the rigorous requirements of the NHS and other public healthcare institutions are well-suited to pursue similar contracts in the future.